Product Information
METHYLPHENIDATE 5 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1309 per EA under NDC 75834032401. Its NADAC has been published 94 times since Nov 6, 2024.
FDA first approved this application on Feb 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834032401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208737FDA Approved
2/1/2019
TE Code
AB
On Market Since
4/16/2024
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG TABLET has been published 94 times since Nov 6, 2024, and over the history we have for it it has declined 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1309 per EA |
|---|---|
| All-time high | $0.1434 (Feb 11, 2026) |
| All-time low | $0.1071 (Nov 20, 2024) |
| 52-week high | $0.1434 |
| 52-week low | $0.1309 |
| Median price | $0.1357 |
| Average price | $0.1332 |
| Largest weekly change | -22.4% (Nov 20, 2024) |
| Weeks tracked | 94 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1309 per EA (NDC 75834032401), effective Aug 19, 2026.
How has the price of METHYLPHENIDATE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG TABLET has declined 5.1%. It has been tracked across 94 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG TABLET?
Since Nov 6, 2024, the NADAC for METHYLPHENIDATE 5 MG TABLET has ranged from a low of $0.1071 (Nov 20, 2024) to a high of $0.1434 (Feb 11, 2026), with a median of $0.1357 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 5 MG TABLET?
METHYLPHENIDATE 5 MG TABLET (NDC 75834032401) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.